DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,978 filers reported holding DANAHER CORPORATION in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,193,882 | -9.9% | 16,904 | -12.9% | 0.58% | -9.9% |
| Q2 2023 | $4,656,720 | +6.3% | 19,403 | +11.6% | 0.64% | +0.3% |
| Q1 2023 | $4,381,211 | +93196.7% | 17,383 | -1.8% | 0.64% | -5.3% |
| Q4 2022 | $4,696 | -99.9% | 17,694 | +1.1% | 0.67% | -8.4% |
| Q3 2022 | $4,521,000 | -0.5% | 17,505 | -2.4% | 0.74% | +5.8% |
| Q2 2022 | $4,545,000 | -14.8% | 17,928 | -1.4% | 0.70% | -2.4% |
| Q1 2022 | $5,332,000 | -9.1% | 18,178 | +1.9% | 0.71% | -4.6% |
| Q4 2021 | $5,867,000 | +7.5% | 17,831 | -0.6% | 0.75% | -5.8% |
| Q3 2021 | $5,459,000 | +6.8% | 17,930 | -5.9% | 0.79% | +11.7% |
| Q2 2021 | $5,112,000 | +17.7% | 19,049 | -1.2% | 0.71% | +12.4% |
| Q1 2021 | $4,342,000 | -10.9% | 19,290 | -12.1% | 0.63% | -15.8% |
| Q4 2020 | $4,875,000 | +5.3% | 21,944 | +2.0% | 0.75% | -13.5% |
| Q3 2020 | $4,631,000 | +21.5% | 21,506 | -0.2% | 0.87% | +15.6% |
| Q2 2020 | $3,810,000 | -7.2% | 21,544 | -27.4% | 0.75% | -23.6% |
| Q1 2020 | $4,106,000 | -12.1% | 29,667 | -2.5% | 0.98% | +22.5% |
| Q4 2019 | $4,670,000 | +2.1% | 30,430 | -4.0% | 0.80% | -2.9% |
| Q3 2019 | $4,576,000 | +2.1% | 31,684 | +1.0% | 0.82% | +0.1% |
| Q2 2019 | $4,484,000 | +0.1% | 31,372 | -7.6% | 0.82% | -5.3% |
| Q1 2019 | $4,481,000 | +12.4% | 33,939 | -12.2% | 0.87% | -1.2% |
| Q4 2018 | $3,988,000 | +22.1% | 38,674 | +28.7% | 0.88% | +40.5% |
| Q3 2018 | $3,265,000 | +10.1% | 30,045 | 0.0% | 0.63% | +4.3% |
| Q2 2018 | $2,965,000 | +6.9% | 30,045 | +6.0% | 0.60% | +10.3% |
| Q1 2018 | $2,774,000 | +6.3% | 28,337 | +0.8% | 0.54% | +7.3% |
| Q4 2017 | $2,610,000 | +7.8% | 28,121 | -0.4% | 0.51% | +2.6% |
| Q3 2017 | $2,421,000 | -1.7% | 28,228 | -3.3% | 0.50% | -8.2% |
| Q2 2017 | $2,463,000 | -2.5% | 29,191 | -1.2% | 0.54% | -5.4% |
| Q1 2017 | $2,527,000 | +9.5% | 29,546 | -0.3% | 0.57% | +7.5% |
| Q4 2016 | $2,308,000 | -0.9% | 29,645 | -0.2% | 0.53% | -4.5% |
| Q3 2016 | $2,329,000 | -22.5% | 29,708 | -0.2% | 0.56% | -33.8% |
| Q2 2016 | $3,005,000 | +3.5% | 29,757 | -2.8% | 0.84% | +4.4% |
| Q1 2016 | $2,904,000 | +2.1% | 30,609 | 0.0% | 0.80% | -1.7% |
| Q4 2015 | $2,843,000 | +8.5% | 30,609 | -0.5% | 0.82% | +5.1% |
| Q3 2015 | $2,621,000 | -8.0% | 30,761 | -7.5% | 0.78% | +2.2% |
| Q2 2015 | $2,848,000 | -19.1% | 33,271 | -19.8% | 0.76% | -15.4% |
| Q1 2015 | $3,522,000 | -0.7% | 41,483 | +0.2% | 0.90% | -5.9% |
| Q4 2014 | $3,548,000 | +12.8% | 41,394 | 0.0% | 0.96% | +15.9% |
| Q3 2014 | $3,145,000 | -4.1% | 41,394 | -0.6% | 0.82% | -2.5% |
| Q2 2014 | $3,279,000 | +4.4% | 41,650 | -0.5% | 0.85% | -0.9% |
| Q1 2014 | $3,140,000 | -3.8% | 41,862 | -1.0% | 0.85% | -3.4% |
| Q4 2013 | $3,263,000 | +10.0% | 42,270 | -1.2% | 0.88% | +5.9% |
| Q3 2013 | $2,966,000 | +5.8% | 42,791 | -3.4% | 0.84% | +4.4% |
| Q2 2013 | $2,804,000 | – | 44,301 | – | 0.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |